These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11600830)

  • 21. HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension.
    Reiberger T; Ferlitsch A; Sieghart W; Kreil A; Breitenecker F; Rieger A; Schmied B; Gangl A; Peck-Radosavljevic M
    J Viral Hepat; 2010 Jun; 17(6):400-9. PubMed ID: 19780945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of chronic hepatitis C virus infection on HIV disease and progression in intravenous drug users.
    Haydon GH; Flegg PJ; Blair CS; Brettle RP; Burns SM; Hayes PC
    Eur J Gastroenterol Hepatol; 1998 Jun; 10(6):485-9. PubMed ID: 9855064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risks factors of liver fibrosis in a cohort of intravenous drug users coinfected with HIV and HCV in the HAART era: the role of mixed steatosis.
    Lanternier F; Roulot D; Bentata M; Pol S; Viard JP; Gordien E; Jeantils V; Ziol M; Lortholary O
    Gastroenterol Clin Biol; 2007 Oct; 31(10):822-7. PubMed ID: 18166860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and histological characteristics of HIV and hepatitis C virus-co-infected patients in Brazil: a case series study.
    Mendes-Correa MC; Widman A; Brussi ML; Guastini CF; Cavalheiro Nde P; Melo CE; Barone AA; Gianini RJ
    Rev Inst Med Trop Sao Paulo; 2008; 50(4):213-7. PubMed ID: 18813760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade.
    Bregenzer A; Conen A; Knuchel J; Friedl A; Eigenmann F; Näf M; Ackle P; Roth M; Fux CA
    Swiss Med Wkly; 2017; 147():w14544. PubMed ID: 29185250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. There is no difference in hepatic fibrosis rates of patients infected with hepatitis C virus and those co-infected with HIV.
    Souza AR; Tovo CV; Mattos AA; Chaves S
    Braz J Med Biol Res; 2008 Mar; 41(3):223-8. PubMed ID: 18176724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of hepatitis C virus genotypes and HIV infection on histological severity of chronic hepatitis C. The Hepatitis/HIV Spanish Study Group.
    García-Samaniego J; Soriano V; Castilla J; Bravo R; Moreno A; Carbó J; Iñiguez A; González J; Muñoz F
    Am J Gastroenterol; 1997 Jul; 92(7):1130-4. PubMed ID: 9219784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Considerable under-treatment of chronic HCV infection in HIV patients despite acceptable sustained virological response rates in a real-life setting.
    Reiberger T; Obermeier M; Payer BA; Baumgarten A; Weitner L; Moll A; Christensen S; Köppe S; Kundi M; Rieger A; Peck-Radosavljevic M
    Antivir Ther; 2011; 16(6):815-24. PubMed ID: 21900713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Chronic hepatitis C in patients with HIV/HCV coinfection with high CD4+ lymphocytes count].
    Inglot M; Szymczak A; Gładysz A; Małyszczak K; Zalewska M
    Przegl Epidemiol; 2007; 61(3):535-43. PubMed ID: 18069391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic hepatitis B and other correlates of spontaneous clearance of hepatitis C virus among HIV-infected people with hemophilia.
    Melendez-Morales L; Konkle BA; Preiss L; Zhang M; Mathew P; Eyster ME; Goedert JJ
    AIDS; 2007 Jul; 21(12):1631-6. PubMed ID: 17630559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection against persistence of hepatitis C.
    Mehta SH; Cox A; Hoover DR; Wang XH; Mao Q; Ray S; Strathdee SA; Vlahov D; Thomas DL
    Lancet; 2002 Apr; 359(9316):1478-83. PubMed ID: 11988247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C virus viremia in HIV-infected individuals with negative HCV antibody tests.
    George SL; Gebhardt J; Klinzman D; Foster MB; Patrick KD; Schmidt WN; Alden B; Pfaller MA; Stapleton JT
    J Acquir Immune Defic Syndr; 2002 Oct; 31(2):154-62. PubMed ID: 12394793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Chronic hepatitis C in HIV co-infected patients. Study of 55 cases with liver biopsy].
    Rubio Caballero M; Rubio Rivas C; Egido García R; Nogués Biau A
    Med Clin (Barc); 2004 Oct; 123(12):441-4. PubMed ID: 15498438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The association of human immunodeficiency virus infection with spontaneously resolved hepatitis C virus infection and level of viremia among injection drug users.
    Seal KH; Monto A; Dove L; Shen H; Vittinghoff E; Tracy D; Miller E; Lau E; Wright TL
    Dig Dis Sci; 2007 Dec; 52(12):3423-30. PubMed ID: 17443407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cryoglobulinaemia vasculitis in patients coinfected with HIV and hepatitis C virus.
    Saadoun D; Aaron L; Resche-Rigon M; Pialoux G; Piette JC; Cacoub P;
    AIDS; 2006 Apr; 20(6):871-7. PubMed ID: 16549971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.
    Chen X; He JM; Ding LS; Zhang GQ; Zou XB; Zheng J
    Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV, age, and the severity of hepatitis C virus-related liver disease: a cohort study.
    Kirk GD; Mehta SH; Astemborski J; Galai N; Washington J; Higgins Y; Balagopal A; Thomas DL
    Ann Intern Med; 2013 May; 158(9):658-66. PubMed ID: 23440167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HCV genotype analysis in HCV-HIV-co-infected Puerto Ricans who are injecting drug users: undetermined and mixed infections.
    Ríos-Olivares E; Yamamura Y; Gómez MA; Guzmán L; Rodríguez N; Fernández D; Hunter Mellado R
    Cell Mol Biol (Noisy-le-grand); 2001 Sep; 47(6):1017-24. PubMed ID: 11785651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of chronic hepatitis C in human immunodeficiency virus infected patients].
    Begovac J; Romih V
    Acta Med Croatica; 2009 Dec; 63(5):423-9. PubMed ID: 20198902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High prevalence of GB virus C/hepatitis G virus infection among homosexual men infected with human immunodeficiency virus type 1: evidence for sexual transmission.
    Nerurkar VR; Chua PK; Hoffmann PR; Dashwood WM; Shikuma CM; Yanagihara R
    J Med Virol; 1998 Oct; 56(2):123-7. PubMed ID: 9746067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.